Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MVD | P53602 | 1/20 | 0.43 |
| ▸ | LTA4H | P09960 | 3/20 | 0.42 |
| ▸ | SLC6A9 | P48067 | 2/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.42 |
| ▸ | EYA2 | O00167 | 1/20 | 0.42 |
| ▸ | APP | P05067 | 1/20 | 0.42 |
| ▸ | ACE | P12821 | 1/20 | 0.42 |
| ▸ | BHMT | Q93088 | 1/20 | 0.42 |
| ▸ | KDM4C | Q9H3R0 | 8/20 | 0.40 |
| ▸ | KDM5A | P29375 | 7/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.40 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.40 |
| ▸ | TSHR | P16473 | 1/20 | 0.40 |
| ▸ | DRD1 | P21728 | 1/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22815161 | 0.95 | TDP1 (0.46) | MVDLTA4HSLC6A9TDP1EYA2 | |
| SCHEMBL11723098 | 0.90 | LTA4H (0.49) | MVDLTA4HSLC6A9TDP1EYA2 | |
| SCHEMBL918386 | 0.89 | TDP1 (0.50) | MVDLTA4HSLC6A9TDP1EYA2 | |
| SCHEMBL7782460 | 0.86 | LTA4H (0.39) | MVDLTA4HSLC6A9BHMTKDM4C | |
| SCHEMBL9973821 | 0.86 | TDP1 (0.56) | MVDLTA4HSLC6A9TDP1EYA2 | |
| SCHEMBL14385366 | 0.85 | CA12 (0.55) | MVDLTA4HSLC6A9TDP1EYA2 | |
| SCHEMBL24141080 | 0.84 | TDP1 (0.58) | MVDLTA4HSLC6A9TDP1EYA2 | |
| SCHEMBL19525673 | 0.83 | MVD (0.42) | MVDLTA4HSLC6A9TDP1EYA2 | |
| SCHEMBL868479 | 0.83 | KDM4C (0.52) | MVDLTA4HSLC6A9TDP1KDM4C | |
| SCHEMBL29222973 | 0.83 | MVD (0.42) | MVDLTA4HSLC6A9TDP1EYA2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240018110-A1 | RADIOLABELED COMPOUNDS TARGETING THE PROSTATE-SPECIFIC MEMBRANE ANTIGEN | ALPHA-9 ONCOLOGY INC. (CA) | 2024-01-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240018110-A1 | RADIOLABELED COMPOUNDS TARGETING THE PROSTATE-SPECIFIC MEMBRANE ANTIGEN | KLK3, FOLH1, TMEM14C | MVD 657/4885LTA4H 1886/4885SLC6A9 1706/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.